{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:29:35Z","timestamp":1790886575381,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Inflammatory bowel disease (IBD) is a global healthcare problem that affects around 3 million people in the United States. Although the impact of gender-affirming hormone therapy (GAHT) on IBD severity has been studied in cisgender patients, there is currently no literature on the impact of exogenous hormone therapy (HT) in transgender and nonbinary (TGNB) individuals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective chart review of TGNB adults diagnosed with IBD and treated with HT for gender dysphoria at Johns Hopkins Hospital (2015-2022). We aimed to determine whether the use of GAHT was associated with subsequent increase in IBD severity. We compared the incidence of flares before vs after GAHT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-two patients were analyzed. More than half (59%) of them were assigned female at birth, identified as transmen, and underwent masculinizing HT. Their median (interquartile range) age was 30 (25-36) years. More patients had Crohn\u2019s disease compared with ulcerative colitis (13 [59.1%] vs 9 [40.9%], P\u2005=\u2005.23) with a median IBD duration of 6.2 (1.8-12.3) years. Nine (41%) patients were on biologics. Of 15 patients on HT, 8 (36.3%) experienced at least one flare. Most of them were treated with steroids (66.7%), and 6 (40%) required hospital or emergency room admission. The proportion of patients who flared after GAHT was similar to that before GAHT: 9 (60%) vs 8 (53.3%), P\u2005=\u20051.0.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>GAHT was not associated with increased incidence of flares. Larger prospective randomized studies are needed to confirm our findings and understand the interaction between GAHT and IBD in TGNB individuals.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izae236","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T07:28:29Z","timestamp":1729063709000},"page":"1833-1840","source":"Crossref","is-referenced-by-count":3,"title":["The Impact of Hormone Therapy on Inflammatory Bowel Disease in Transgender and Nonbinary Individuals"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-8740","authenticated-orcid":false,"given":"Bashar","family":"Hassan","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Center for Transgender and Gender Expansive Health, Johns Hopkins University , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Suchan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins Bayview Medical Center , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madyson","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Center for Transgender and Gender Expansive Health, Johns Hopkins University , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Kishan","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Center for Transgender and Gender Expansive Health, Johns Hopkins University , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Center for Transgender and Gender Expansive Health, Johns Hopkins University , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4319-9278","authenticated-orcid":false,"given":"Brindusa","family":"Truta","sequence":"additional","affiliation":[{"name":"The Permanente Medical Group, Department of Medicine, Division of Gastroenterology, South San Francisco Medical Center , South San Francisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"42","key":"2025070803364805100_CIT0001","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","article-title":"Prevalence of inflammatory bowel disease among adults aged \u226518 years\u2014United States, 2015","volume":"65","author":"Dahlhamer","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"4","key":"2025070803364805100_CIT0002","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/mog.0000000000000736","article-title":"The impact of inflammatory bowel disease on women\u2019s life","volume":"37","author":"Truta","year":"2021","journal-title":"Curr Opin Gastroenterol."},{"issue":"11","key":"2025070803364805100_CIT0003","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/ibd\/izac094","article-title":"Sex-related differences in inflammatory bowel diseases: the potential role of sex hormones","volume":"28","author":"Xu","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2025070803364805100_CIT0004","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/1751-2980.12247","article-title":"Menstrual cycle, sex hormones in female inflammatory bowel disease patients with and without surgery","volume":"16","author":"Bharadwaj","year":"2015","journal-title":"J Dig Dis."},{"issue":"12","key":"2025070803364805100_CIT0005","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41575-020-0354-0","article-title":"Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease","volume":"17","author":"Goodman","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"5","key":"2025070803364805100_CIT0006","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1572-0241.2007.01700.x","article-title":"Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol."},{"issue":"6123","key":"2025070803364805100_CIT0007","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","article-title":"Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity","volume":"339","author":"Markle","year":"2013","journal-title":"Science."},{"issue":"2","key":"2025070803364805100_CIT0008","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","article-title":"Gender bias in autoimmunity is influenced by microbiota","volume":"39","author":"Yurkovetskiy","year":"2013","journal-title":"Immunity."},{"issue":"3","key":"2025070803364805100_CIT0009","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/cells8030261","article-title":"A direct effect of sex hormones on epithelial barrier function in inflammatory bowel disease models","volume":"8","author":"van der Giessen","year":"2019","journal-title":"Cells."},{"issue":"2","key":"2025070803364805100_CIT0010","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/jpm13020165","article-title":"Impact of female gender in inflammatory bowel diseases: a narrative review","volume":"13","author":"Lungaro","year":"2023","journal-title":"J Pers Med."},{"issue":"10","key":"2025070803364805100_CIT0011","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/MIB.0000000000000134","article-title":"The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases","volume":"20","author":"Gawron","year":"2014","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025070803364805100_CIT0012","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/ibd\/izx004","article-title":"The influence of hormonal fluctuation on inflammatory bowel disease symptom severity\u2014a cross-sectional cohort study","volume":"24","author":"Rolston","year":"2018","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2025070803364805100_CIT0013","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/trgh.2018.0014","article-title":"What is gender dysphoria? A critical systematic narrative review","volume":"3","author":"Davy","year":"2018","journal-title":"Transgend Health"},{"key":"2025070803364805100_CIT0014","article-title":"How Many Adults and Youth Identify as Transgender in the United States? Los Angeles, California","author":"Herman","year":"2022"},{"issue":"suppl. 1","key":"2025070803364805100_CIT0015","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of Care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"4","key":"2025070803364805100_CIT0016","doi-asserted-by":"publisher","first-page":"bvab011","DOI":"10.1210\/jendso\/bvab011","article-title":"Hormone therapy, mental health, and quality of life among transgender people: a systematic review","volume":"5","author":"Baker","year":"2021","journal-title":"J Endocr Soc."},{"issue":"1","key":"2025070803364805100_CIT0017","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.gastro.2012.10.003","article-title":"Brain-gut interactions in inflammatory bowel disease","volume":"144","author":"Bonaz","year":"2013","journal-title":"Gastroenterology."},{"issue":"3","key":"2025070803364805100_CIT0018","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/trgh.2022.0079","article-title":"Higher rates of certain autoimmune diseases in transgender and gender diverse youth","volume":"9","author":"Logel","year":"2023","journal-title":"Transgend Health."},{"issue":"8","key":"2025070803364805100_CIT0019","doi-asserted-by":"publisher","first-page":"e2015036","DOI":"10.1001\/jamanetworkopen.2020.15036","article-title":"Assessment of health conditions and health service use among transgender patients in Canada","volume":"3","author":"Abramovich","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2025070803364805100_CIT0020","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/MPG.0000000000003027","article-title":"Recommendations for transgender and gender nonconforming adolescents and young adults with inflammatory bowel disease","volume":"72","author":"Schenker","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2025070803364805100_CIT0021","article-title":"IBM SPSS Statistics 29 Brief Guide","author":"George"},{"issue":"3","key":"2025070803364805100_CIT0022","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40264-015-0372-y","article-title":"Risk of inflammatory bowel disease with oral contraceptives and menopausal hormone therapy: current evidence and future directions","volume":"39","author":"Khalili","year":"2016","journal-title":"Drug Saf."},{"issue":"9","key":"2025070803364805100_CIT0023","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1097\/MEG.0000000000000915","article-title":"Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies","volume":"29","author":"Ortizo","year":"2017","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"3","key":"2025070803364805100_CIT0024","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/apt.16647","article-title":"Use of contraceptives and risk of inflammatory bowel disease: a nested case\u2013control study","volume":"55","author":"Pasvol","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2025070803364805100_CIT0025","doi-asserted-by":"publisher","first-page":"G118","DOI":"10.1152\/ajpgi.00024.2003","article-title":"Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease","volume":"286","author":"Harnish","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"6","key":"2025070803364805100_CIT0026","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1042\/EBC20210010","article-title":"Estrogen receptor actions in colitis","volume":"65","author":"Garcia-Villatoro","year":"2021","journal-title":"Essays Biochem."},{"issue":"2","key":"2025070803364805100_CIT0027","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1006\/bbrc.1997.7683","article-title":"Estrogen receptor alpha and beta expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats","volume":"240","author":"Campbell-Thompson","year":"1997","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"2025070803364805100_CIT0028","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jcmgh.2018.01.017","article-title":"Estrogen-mediated effects underlie gender bias in inflammatory bowel disease","volume":"5","author":"De Simone","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"2025070803364805100_CIT0029","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1034\/j.1600-0463.2001.090503.x","article-title":"Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER alpha and ER beta mRNA with real-time RT-PCR","volume":"109","author":"Pfaffl","year":"2001","journal-title":"APMIS."},{"issue":"2-3","key":"2025070803364805100_CIT0030","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0960-0760(03)00025-6","article-title":"The gastrointestinal tract as target of steroid hormone action: quantification of steroid receptor mRNA expression (AR, ERalpha, ERbeta and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR","volume":"84","author":"Pfaffl","year":"2003","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"8","key":"2025070803364805100_CIT0031","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1073\/pnas.0511271103","article-title":"Role of estrogen receptor beta in colonic epithelium","volume":"103","author":"Wada-Hiraike","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"issue":"8","key":"2025070803364805100_CIT0032","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s10620-017-4631-x","article-title":"Estradiol has differential effects on acute colonic inflammation in the presence and absence of estrogen receptor \u03b2 expression","volume":"62","author":"Armstrong","year":"2017","journal-title":"Dig Dis Sci."},{"issue":"4","key":"2025070803364805100_CIT0033","doi-asserted-by":"publisher","first-page":"G621","DOI":"10.1152\/ajpgi.00274.2010","article-title":"Estrogen receptor-\u03b2 signaling modulates epithelial barrier function","volume":"300","author":"Looijer-van Langen","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"11","key":"2025070803364805100_CIT0034","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1002\/ijc.27578","article-title":"Estrogen receptor-\u03b2 protects against colitis-associated neoplasia in mice","volume":"131","author":"Saleiro","year":"2012","journal-title":"Int J Cancer."},{"issue":"10","key":"2025070803364805100_CIT0035","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1007\/s10620-017-4717-5","article-title":"Ratio of circulating estrogen receptors beta and alpha (ER\u03b2\/ER\u03b1) indicates endoscopic activity in patients with Crohn\u2019s disease","volume":"62","author":"Linares","year":"2017","journal-title":"Dig Dis Sci."},{"issue":"38","key":"2025070803364805100_CIT0036","doi-asserted-by":"publisher","first-page":"40443","DOI":"10.18632\/oncotarget.6217","article-title":"Linking estrogen receptor \u03b2 expression with inflammatory bowel disease activity","volume":"6","author":"Pierdominici","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"2025070803364805100_CIT0037","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/hmbci-2015-0014","article-title":"Testosterone therapy in men with Crohn\u2019s disease improves the clinical course of the disease: data from long-term observational registry study","volume":"22","author":"Nasser","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"6","key":"2025070803364805100_CIT0038","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1370\/afm.2586","article-title":"Insurance coverage and use of hormones among transgender respondents to a national survey","volume":"18","author":"Stroumsa","year":"2020","journal-title":"Ann Fam Med."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izae236\/59771613\/izae236.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/7\/1833\/59771613\/izae236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/7\/1833\/59771613\/izae236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:36:53Z","timestamp":1751960213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/7\/1833\/7823327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,10,16]]},"published-print":{"date-parts":[[2025,7,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae236","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2024,10,16]]}}}